skip nav
Contact Us Live Help M-F 9am-6pm ET Contáctenos Ayuda en vivo L-V 9am-6pm (HE)
National Prevention Information Network Spanish
Search Help
1-800-458-5231, M-F 9am-6pm (ET)
Tuberculosis
*What's New

*TB Today

*Elimination and
Control Today


*Making the
Connection


*CDC Guidelines and
Recommendations


*Program
Management


*Testing and
Treatment


*Surveillance and Data
Management


*Education and
Training


*FAQs and Basic
Facts


HIV/AIDS
Hepatitis
STDs
Communities at Risk
Partner Forum
Web Tools
Home

TB Testing and Treatment

Three basic strategies are critical to the prevention and control of TB:

  • Identifying and completely treating all persons who have active TB.
  • Finding and evaluating persons who have had contact with TB patients, determining if they have TB infection or disease, and treating them appropriately (contact investigations). Contact investigations are important for identifying persons who have active TB and infected persons at high risk for developing TB.
  • Screening populations at high risk for TB to locate persons infected with TB and giving complete therapy to prevent the infection from progressing to active, contagious disease. This screening also may identify cases of active disease.

* Featured TB Testing and Treatment Information
* Locate TB Services


Featured TB Testing and Treatment Information

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection
From CDC’s Division of Tuberculosis Elimination

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
From CDC’s MMWR Recommendations and Reports June 25, 2010 / 59(RR05);1-25

Severe Isoniazid-Associated Liver Injuries Among Persons Being Treated for Latent Tuberculosis Infection — United States, 2004 – 2008
From CDC’s MMWR Weekly; March 5, 2010 / 59(08);224-229

Testing and Diagnostic Resources
From CDC's Division of Tuberculosis Elimination

Treatment Resources
From CDC's Division of Tuberculosis Elimination

TB and HIV/AIDS
From CDC's Division of HIV/AIDS Prevention

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
From CDC's Division of Tuberculosis Elimination

MMWR: Reported HIV Status of Tuberculosis Patients—United States, 1993–2005
From CDC’s MMWR Weekly October 26, 2007 / 56(42);1103-1106

Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
From CDC’s Division of Tuberculosis Elimination

Mantoux Tuberculin Skin Test Training Materials Kit
Material available from the Division of TB Elimination (DTBE) of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Diagnosis and Treatment Resources
From the New Jersey Medical School Global Tuberculosis Institute

Treatment of Tuberculosis Infection and Disease
From the New Jersey Medical School Global Tuberculosis Institute

top of pageBack to Top


Page Last Updated: September 21, 2010

Tuberculosis icon

Specific Searches
HIV/STD Testing Sites
Organizations
Downloadable Materials
Conferences
Funding

Learn More
Electronic Mailing Lists
Statistics
Social Marketing and Education Campaigns
NPIN Feeds
Telebriefings/Webcasts
 
About Us Help Using the CDC NPIN Web Site HIV Content Notice Privacy Policy Policies & Disclaimers Site Index
The people in the photos on this Web site are models and used for illustrative purposes only.
A service of the Centers for Disease Control and Prevention